NovoCure Limited (NVCR) Financials

NVCR Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 1.1 billion 762.1 million
2023-12-31 1.1 billion 783.6 million
2023-09-30 1.1 billion 752.6 million
2023-06-30 1.2 billion 743.3 million

NVCR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -43.4 million 34.1 million
2023-12-31 -21.4 million 17.4 million
2023-09-30 -26.6 million 26.3 million
2023-06-30 -29.7 million 32.7 million

NVCR Net Income

No data available :(

NVCR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 870.1 million - 25.6 million
2023-12-31 910.6 million - 27.4 million
2023-09-30 921.2 million - 22.1 million
2023-06-30 940.8 million 567.2 million 20.3 million

NVCR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 107.3 million
2023-12-31 107.0 million
2023-09-30 106.8 million
2023-06-30 106.3 million

NVCR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 11.8 million 51.6 million 39.5 million 55.2 million
2023-12-31 6.8 million 54.3 million 39.4 million 59.2 million
2023-09-30 7.3 million 53.6 million 41.9 million 58.0 million
2023-06-30 6.9 million 55.4 million 40.8 million 58.5 million

NVCR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 138.5 million 33.7 million
2023-12-31 133.8 million 32.6 million
2023-09-30 127.3 million 32.1 million
2023-06-30 126.1 million 34.0 million

NVCR

Price: $14.78

52 week price:
10.87
83.60

Earnings Per Share: -1.95 USD

P/E Ratio: -8.40

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 542600

Ebitda: -3.9 million

Market Capitalization: 1.6 billion

Links: